ARTICLE | Finance
China's newco engine
How I-Bridge systematically creates new biotechs in China
September 5, 2016 7:00 AM UTC
Now that I-Bridge Capital has formed five companies and is in the process of launching two more, the firm is laying claim to being the only Chinese VC exclusively dedicated to life science company creation in the country. The newest entrant is iPharma, a JV with BioLineRx Ltd. (Tel Aviv:BLRX; NASDAQ:BLRX) that debuted on Aug. 25 and typifies I-Bridge's approach of bringing novel science to China from other countries.
Jimmy Wei launched I-Bridge last year after working for four years at KPCB China, where he also created a handful Chinese biotechs from whole cloth...